CVS Health Reports Record Fourth Quarter And Full Year Results For 2016; Confirms 2017 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
CVS Health (CVS) PT Raised to $89 at UBS
February 10, 2017 8:51 AM ESTUBS analyst Michael Cherny reiterates Buy rating and raises price target on CVS Health Corp. (NYSE: CVS) to $89 (from $88.50), suggesting the companys continued PBM net new business is offset by ongoing weakness in retail.
Cherny comments, "CVS 4Q had a number of... More
CVS Health (CVS) PT Lowered to $84 at Evercore ISI; Keeps 'Buy'
February 9, 2017 12:11 PM ESTEvercore ISI lowered its price target on CVS Health (NYSE: CVS) to $84.00 (from $91.50) while maintaining a Buy rating. The analyst said management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates.
Analyst Ross Muken commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below dollar profit... More
CVS Health (CVS) Tops Q4 EPS by 4c; Confirms Outlook
February 9, 2017 6:56 AM ESTCVS Health (NYSE: CVS) reported Q4 EPS of $1.71, $0.04 better than the analyst estimate of $1.67. Revenue for the quarter came in at $46 billion versus the consensus estimate of $46.5 billion.
Net revenues increased 11.7% to $46.0 billionOperating profit in line with Company\'s expectationsGAAP... More